Latest Headlines

Latest Headlines

NEA-backed Cartiva raises $6M after a recent FDA nod, as it heads into a PMA review

Cartiva has raised $6 million to back its musculoskeletal foot surgical products from a single investor just ahead of its first PMA review. The financing could be expanded to up to $8.5 million, according to an SEC filing. The startup has previously identified New Enterprise Associates, which has a partner on its board, as its primary investor.

Merck KGaA shareholders rewarded for hard work of turning company around

Merck KGaA Chairman Karl-Ludwig Kley is feeling pretty good about the hard work his company has accomplished in the last three years or so. A tough series of job cuts helped it exceed cost-cutting goals.

Roche, Novartis to halt marketing for unreimbursed cancer drugs in Australia

Swiss drugmakers Roche and Novartis Oncology have told Australia to go fly a kite if it expects a company to market a cancer drug in the country without Pharmaceutical Benefits Scheme coverage. The two companies announced their boycott intentions ahead of a Monday hearing by a panel of Australia's Senate.

Q1 med tech venture dips to lowest since 2013--but med tech IPOs outpace biotech

The venture capital invested in med tech startups dipped below $500 million during the first quarter--for the first time since the fourth quarter of 2013, according to the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association based on data provided by Thomson Reuters.

3-D printed prosthetic market worth $537M. Are 3-D printed organs next?

Terry Wohlers, president of 3-D printing consultancy Wohlers Associates, said 3-D printed body parts earned $537 million last year, an increase of 30%.

Drug-eluting bone filler startup gets $14M led by Scandinavian pension fund

Swedish startup BoneSupport has raised $14 million to back the drug-eluting aspects of its synthetic bone substitute. Its injectable, antibiotic-eluting product Cerament G was CE marked in 2013 and is the first such product indicated to promote and protect healing in patients with bone infections.

China's big pharma companies get thumbs-up from Moody's on reform push

Moody's Investors Service has given a thumbs-up to the credit outlook for big Chinese pharmaceutical companies, noting that a reform push by the government for more market-friendly policies and stronger safety guidelines promises sweeping changes to an industry sometimes viewed with suspicion because of safety lapses.

NEA closes funds worth $3.1B after spate of Abbott med tech deals

New Enterprise Associates has closed a pair of funds totaling $3.15 billion to invest in information technology and healthcare companies. And while med tech may not loom particularly large for NEA, the firm does have roughly a couple of dozen active medical device portfolio companies.

Startup raises $4M for sterilization with vaporized hydrogen peroxide

Sterilucent has raised almost $4 million just about 6 months after the FDA cleared its Sterilucent PSD-85 Hydrogen Peroxide Sterilizer for use in healthcare facilities with tough surroundings such as combat hospitals and disaster response sites.

EarlySense nabs Mitsui as Japan partner, investor and ups financing to $25M

EarlySense has brought a third strategic investor into its latest financing round, and Mitsui & Co. has partnered exclusively with the startup to market its continuous, contact-free patient monitoring solution to Japanese homes and hospitals.